Diamond Drugs Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 30-06-2024
- Paid Up Capital ₹ 1.13 Cr
as on 30-06-2024
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.10 Cr
as on 30-06-2024
- Satisfied Charges ₹ 0.50 Cr
as on 30-06-2024
- Revenue 23.73%
(FY 2022)
- Profit 99.37%
(FY 2022)
- Ebitda 84.24%
(FY 2022)
- Net Worth 31.27%
(FY 2022)
- Total Assets 24.96%
(FY 2022)
About Diamond Drugs
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 1.13 Cr.
The company currently has active open charges totaling ₹1.10 Cr. The company has closed loans amounting to ₹5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Mihir Sarkar, Silpi Sarkar, and Prabir Sarkar serve as directors at the Company.
- CIN/LLPIN
U24239WB2004PTC100709
- Company No.
100709
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Dec 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Diamond Drugs Private Limited offer?
Diamond Drugs Private Limited offers a wide range of products and services, including Antacid Drugs, Allopathic Liver Tonic, Antibiotic Tablets & Capsules, Azithromycin Tablets, Allopathic Cough Syrup, Guaiphenesin Cough Syrup, Ambroxol Hydrochloride Syrup, Ayurvedic Herbal Syrups & Tonics, Ayurvedic Health Tonic, Antipyretic Medication.
Who are the key members and board of directors at Diamond Drugs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mihir Sarkar  | Director | 15-Dec-2004 | Current |
| Silpi Sarkar | Director | 28-Mar-2007 | Current |
| Prabir Sarkar | Director | 15-Dec-2004 | Current |
Financial Performance and Corporate Structure Insights of Diamond Drugs.
Diamond Drugs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 23.73% increase. The company also saw a substantial improvement in profitability, with a 99.37% increase in profit. The company's net worth Soared by an impressive increase of 31.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Diamond Drugs?
In 2021, Diamond Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sovana Developers Private Limited
Active 15 years 1 monthMihir Sarkar, Silpi Sarkar and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 28 Mar 2015 | ₹1.10 Cr | Open |
State Bank Of India Creation Date: 03 Dec 2005 | ₹5.00 M | Satisfied |
How Many Employees Work at Diamond Drugs?
Diamond Drugs has a workforce of 84 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diamond Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diamond Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
